Document is current
Any future updates will be listed below
-
Authors
Han, Xiaorui https://orcid.org/0000-0002-9058-3363
Skatova, Valeria
Mikelov, Artem https://orcid.org/0000-0002-1629-2373
Ji, Xuhuai https://orcid.org/0000-0002-1768-6403
Hoh, Ramona A.
Lee, Ji-Yeun
Cao, Shu
Seastedt, Hana
Schuetz, Jackson https://orcid.org/0000-0002-1053-2903
Fernandes, Andrea https://orcid.org/0000-0002-2855-4262
Singhal, Arpita
Grubert, Fabian
DeKruyff, Rosemarie H.
Maecker, Holden T. https://orcid.org/0000-0003-0795-9946
Galli, Stephen J. https://orcid.org/0000-0001-5736-5340
Manohar, Monali
Chinthrajah, R. Sharon https://orcid.org/0000-0003-2467-4256
Kasowski, Maya M. https://orcid.org/0000-0001-6583-0759
Boyd, Scott D. https://orcid.org/0000-0003-0963-044X
Nadeau, Kari C. https://orcid.org/0000-0002-2146-2955
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI104209)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI104209)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (U19AI104209)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01AI125567)
- License Information
-
More Information
Article History
Received: 12 January 2025
Accepted: 1 October 2025
First Online: 4 November 2025
Competing interests
: K.C.N. reports grants from NIAID, the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute of Environmental Health Sciences; support from Food Allergy Research & Education; directorship of the World Allergy Organization Center of Excellence at Stanford; and advisership at COUR Pharma. She is cofounder of Before Brands, Alladapt, Latitude and IgGenix. She is a member of the National Scientific Committee at the Immune Tolerance Network and the NIH clinical research centers. She is a member of the Data and Safety Monitoring Board for the NHLBI. She holds US patents for basophil testing, multi-food immunotherapy and prevention, monoclonal antibody from plasmablasts, and device for diagnostics. S.J.G. reports grants from the NIH, is a scientific adviser and grant recipient of Evommune, sits on the Scientific Advisory Board of Jasper Therapeutics, and is a member of the Board of Directors of Atossa Therapeutics. S.D.B. has consulted for Regeneron, Sanofi, Novartis, Genentech and Visterra on topics unrelated to this study; owns shares in AbCellera; has patents awarded or submitted related to adaptive immune receptor gene and protein analysis; and reports grants from the NIH. R.S.C. receives grant support from the Consortium for Food Allergy Research, Aimmune, DBV Technologies, Astellas, AnaptysBio, Novartis and Regeneron, and is an advisory board member for Alladapt Immunotherapeutics, Novartis and Genentech. The other authors declare no competing interests.
